المؤلفون: Chanchlani, Neil, Lin, Simeng, Chee, Desmond, Hamilton, Benjamin, Nice, Rachel, Arkir, Zehra, Bewshea, Claire, Cipriano, Bessie, Derikx, Lauranne A. A. P., Dunlop, Allan, Greathead, Louise, Griffiths, Rachel L., Ibraheim, Hajir, Kelleher, Peter, Kok, Klaartje B., Lees, Charlie W., MacDonald, Jonathan, Sebastian, Shaji, Smith, Philip J., McDonald, Timothy J., Irving, Peter M., Powell, Nick, Kennedy, Nicholas A., Goodhand, James R., Ahmad, Tariq

المصدر: Chanchlani , N , Lin , S , Chee , D , Hamilton , B , Nice , R , Arkir , Z , Bewshea , C , Cipriano , B , Derikx , L A A P , Dunlop , A , Greathead , L , Griffiths , R L , Ibraheim , H , Kelleher , P , Kok , K B , Lees , C W , MacDonald , J , Sebastian , S , Smith , P J , McDonald , T J , Irving , P M , Powell , N , Kennedy , ....

مصطلحات موضوعية: adalimumab, biologic, CLARITY, COVID-19, immunosuppression, inflammatory bowel disease, infliximab, vaccination, vedolizumab

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1093/ecco-jcc/jjab153Test
https://kclpure.kcl.ac.uk/portal/en/publications/1fd256f3-70ad-4c8d-b7f5-eed520031c42Test
https://kclpure.kcl.ac.uk/ws/files/170412073/Adalimumab_and_Infliximab_Impair_CHANCHLANI_Published_online_2_Sept_21_GOLD_VoR_CC_BY_NC_.pdfTest
http://www.scopus.com/inward/record.url?scp=85126490511&partnerID=8YFLogxKTest

المؤلفون: Claire Bewshea, James R Goodhand, Peter Kelleher, Nick Powell, Rachel L Griffiths, Nicholas A. Kennedy, Philip J Smith, Shaji Sebastian, Arkir Zehra, Bessie Cipriano, Desmond Chee, Louise Greathead, Benjamin Hamilton, Simeng Lin, Rachel Nice, Lauranne A A P Derikx, Neil Chanchlani, Hajir Ibraheim, Peter M. Irving, Klaartje Kok, Charlie W. Lees, Jonathan Macdonald, Timothy J. McDonald, Allan Dunlop, Tariq Ahmad

المصدر: Journal of Crohn's and Colitis, 16, 3, pp. 389-397
Journal of Crohn's & Colitis
Journal of Crohn's and Colitis, 16, 389-397
Chanchlani, N, Lin, S, Chee, D, Hamilton, B, Nice, R, Arkir, Z, Bewshea, C, Cipriano, B, Derikx, L A A P, Dunlop, A, Greathead, L, Griffiths, R L, Ibraheim, H, Kelleher, P, Kok, K B, Lees, C W, MacDonald, J, Sebastian, S, Smith, P J, McDonald, T J, Irving, P M, Powell, N, Kennedy, N A, Goodhand, J R & Ahmad, T 2022, ' Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses : Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients ', Journal of Crohn's & colitis, vol. 16, no. 3, pp. 389-397 . https://doi.org/10.1093/ecco-jcc/jjab153Test

مصطلحات موضوعية: Male, TNF, Gastroenterology, Serology, Seroepidemiologic Studies, adalimumab, skin and connective tissue diseases, immunosuppression, biology, medicine.diagnostic_test, General Medicine, Eccojc/1020, Original Article, Drug Monitoring, Antibody, Life Sciences & Biomedicine, biologic, Inflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5], medicine.drug, vedolizumab, Adult, medicine.medical_specialty, Combination therapy, MATURATION, Vedolizumab, DEFICIENT, inflammatory bowel disease, Internal medicine, Adalimumab, medicine, Humans, Seroprevalence, AcademicSubjects/MED00260, Biological Products, Science & Technology, Gastroenterology & Hepatology, SARS-CoV-2, business.industry, COVID-19, 1103 Clinical Sciences, vaccination, Inflammatory Bowel Diseases, Infliximab, ALPHA, Therapeutic drug monitoring, CLARITY, Antibody Formation, biology.protein, Tumor Necrosis Factor Inhibitors, infliximab, business, INFLAMMATORY-BOWEL-DISEASE

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c08447d7329ab51228946a10f8ee899Test

المؤلفون: Chanchlani, Neil, Lin, Simeng, Chee, Desmond, Hamilton, Benjamin, Nice, Rachel, Arkir, Zehra, Bewshea, Claire, Cipriano, Bessie, Derikx, Lauranne A A P, Dunlop, Allan, Greathead, Louise, Griffiths, Rachel L, Ibraheim, Hajir, Kelleher, Peter, Kok, Klaartje B, Lees, Charlie W, MacDonald, Jonathan, Sebastian, Shaji, Smith, Philip J, McDonald, Timothy J

المصدر: Journal of Crohn's & Colitis; Mar2022, Vol. 16 Issue 3, p389-397, 9p

المؤلفون: Luber, Raphael P., O'Neill, Rhona, Singh, Sukhpreet, Sharma, Esha, Cunningham, Georgina, Honap, Sailish, Meade, Susanna, Ray, Shuvra, Anderson, Simon H., Mawdsley, Joel, Sanderson, Jeremy D., Samaan, Mark A., Arkir, Zehra, Irving, Peter M.

المصدر: Alimentary Pharmacology & Therapeutics; Sep2021, Vol. 54 Issue 5, p678-688, 11p, 1 Illustration, 3 Charts, 3 Graphs

مصطلحات موضوعية: INFLAMMATORY bowel diseases, INFLIXIMAB, PREVENTIVE medicine, ADALIMUMAB, VEDOLIZUMAB, SCIENTIFIC observation, C-reactive protein, DISEASE remission